Syndivia signs a licence agreement with SATT Conectus

Written By Syndivia

STRASBOURG, France, December 19, 2014.

Syndivia and SATT Conectus have signed a licence agreement for APN technology allowing preparation of bioconjugates with increased stability in circulation.

Syndivia https://syndivia.com
Previous

APN technology | CBTF linker | Publication in Bioconjugate Chemistry
Next

Syndivia - Laureate of Prix Région Alsace